Elevation of extracellular cortical noradrenaline may contribute to the antidepressant activity of zotepine: An in vivo microdialysis study in freely moving rats

Neuropharmacology

Volumn 37, Issue 7, 1998, Pages 937-944

  Rowley, Helen L ^a   Kilpatrick, Ian C ^a   Needham, Patricia L ^a   Heal, David J ^a  

^a CNS Biology   (United Kingdom)

Author keywords

Antipsychotics; Frontal cortex; Microdialysis; Noradrenaline uptake; Zotepine

Indexed keywords

CLOZAPINE; DESIPRAMINE; NORADRENALIN; OLANZAPINE; ZIPRASIDONE; ZOTEPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; CALCIUM; DESIPRAMINE; DIBENZOTHIEPINS; EXTRACELLULAR SPACE; FLUOXETINE; FRONTAL LOBE; KINETICS; MALE; MICRODIALYSIS; NOREPINEPHRINE; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031903644     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00094-X     Document Type: Article

References (44)

1. Abercrombie, E.D., Jacobs, B.L., 1987. Microinjected clonidine inhibits noradrenergic neurons of the locus coeruleus in freely moving cats. Neurosci. Lett. 76, 203-208.
2. Abercrombie, E.D., Keller, R.W., Zigmond, M.J., 1988. Characterization of hippocampal norepinephrine release as measured by microdialysis perfusion: pharmacological and behavioural studies. Neuroscience 27, 897-904.
3. Ackenheil, M., 1989. Clozapine - pharmacokinetic investigations and biochemical effects in man. Psychopharmacology 99, S32-S37.
4. Arnt, J., Skarsfeldt, T., 1998. Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 18, 63-101.
5. Breier, A., Buchanan, R.W., Waltrip, R.W., Listwak, S., Holmes, C., Goldstein, D.S., 1994. The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. Neuropsychopharmacology 10, 1-7.
6. Bymaster, F.P., Rasmussen, K., Calligaro, D.O., Nelson, D.L., De-Lapp, N.W., Wong, D.T., Moore, N.A., 1997. In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug. J. Clin. Psychiatry 58 (Suppl 10), 28-36.
7. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology 35, 63-70.
8. Chen, N.-H., Reith, M.E.A., 1994. Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely-moving rats: a microdialysis study on monoamine interrelationships. J. Neurochem. 63, 1701-1713.
9. Dalley, J.W., Stanford, S.C., 1995. Incremental changes in extracellular noradrenaline availability in the frontal cortex induced by naturalistic environmental stimuli: a microdialysis study in the freely-moving rat. J. Neurochem. 65, 2644-2651.
10. Deakin, J.F.W., Simpson, M.D.C., Slater, P., Hellewell, J.S.E., 1997. Familial and developmental abnormalities of frontal lobe function and neurochemistry in schizophrenia. J. Psychopharmacol. 11, 133-142.
11. Dennis, T., L'Heureux, R., Carter, C., Scatton, B., 1987. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo microdialysis) in the rat. J. Pharmacol. Exp. Ther. 241, 642-649.
12. Fleischhacker, W., Barnas, C., Stuppäck, C.H., Unterweger, B., Miller, C., Hinterhuber, H., 1989. Zotepine vs. haloperidol in paranoid schizophrenia: a double-blind trial. Psychopharmacol. Bull. 25, 97-100.
13. 2 sites in the mammalian central nervous system. Pharmacol. Ther. 68, 175-208.
14. 2-autoreceptor function in the hippocampus in vivo. Neuroscience 77, 57-64.
15. Heal, D.J., Needham, P.L., 1996. Comparison of the pharmacological profiles of zotepine and norzotepine. Eur. Neuropsychopharmacol. 6 (Suppl. 3), P9.
16. Hughes, Z.A., Stanford, S.C., 1996. Increased noradrenaline efflux induced by local infusion of fluoxetine in the rat frontal cortex. Eur. J. Pharmacol. 317, 83-90.
17. Iversen, L.L., 1971. Role of transmitter uptake mechanisms in synaptic neurotransmission. Br. J. Pharmacol. 41, 571-591.
18. Kane, J., Honigfeld, G., Singer, J., Meltzer, H., 1988. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch. Gen. Psychiatry 45, 789-796.
19. Langer, L.L., 1981. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32, 337-362.
20. L'Heureux, R., Dennis, T., Curet, O., Scatton, B., 1986. Measurement of endogenous noradrenaline release in the rat cerebral cortex in vivo by transcortical dialysis: effects of drugs affecting noradrenergic transmission. J. Neurochem. 46, 1794-1801.
21. Li, M.-Y., Yan, Q.-S., Coffey, L.L., Reith, M.E.A., 1996. Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers. J. Neurochem. 66, 559-568.
22. 2 antagonist, augments fluphenazine in schizophrenic patients: a pilot study. J. Clin. Psychopharmacol. 13, 264-267.
23. Litman, R.E., Su, T.-P., Potter, W.Z., Hong, W.W., Pickar, D., 1996. Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Br. J. Psychiatry 168, 571-579.
24. Luscombe, G.P., Hopcroft, R.H., Thomas, P.C., Buckett, W.R., 1989. The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology 28, 129-134.
25. Marwaha, J., Aghajanian, G.K., 1982. Relative potencies of alpha-1 and alpha-2 antagonists in the locus coeruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J. Pharmacol. Exp. Ther. 22, 287-293.
26. 1-imidazoline receptors in rat brain. Brain Res. 744, 216-226.
27. Meyer-Lindenberg, A., Gruppe, H., Bauer, U., Lis, S., Krieger, S., Gallhofer, B., 1997. Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study. Pharmacopsychiatry 30, 35-42.
28. Needham, P.L., Atkinson, J., Skill, M.J., Heal, D.J., 1996a. Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile. Psychopharmacol. Bull. 32, 123-128.
29. Needham, P.L., Lancashire, B., Skill, M.J., Heal, D.J., 1996b. Norzotepine: atypical antipsychotic profile of zotepine's major active metabolite. Schizophr. Res. 18 (Suppl. 2,3), 147.
30. Needham, P.L., Skill, M.J., Cheetham, S.C., Heal, D.J., 1997. Zotepine: preclinical support for antidepressant activity. Biol. Psychiatry 42, S175-S176.
31. Nutt, D.J., Holman, R.B., Thomas, D.N., 1992. Noradrenergic mechanisms in anxiolytic and antidepressant drug action. In: Elliott, M.J. (Ed.), Experimental Approaches to Anxiety and Depression. Wiley, Chichester, pp. 101-106.
32. Nutt, D.J., Lalies, M.D., Lione, L.A., Hudson, A.L., 1997. Noradrenergic mechanisms in the prefrontal cortex. J. Psychopharmacol. 11, 163-168.
33. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
34. Petit, M., Raniwalla, J., Tweed, J., Leutenegger, E., Dollfus, S., Kelly, F., 1996. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial. Psychopharmacol. Bull. 32, 81-87.
35. Reith, M.E.A., Li, M.-Y., Yan, Q.-S., 1997. Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely-moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers. Psychopharmacology 134, 309-317.
36. Seeger, T.F., Seymour, P.A., Schmidt, A.W., Zorn, S.H., Schulz, D.W., Lebel, L.A., McLean, S., Guanowsky, V., Howard, H.R., Lowe, J.A., Heym, J., 1995. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity. J. Pharmacol. Exp. Ther. 275, 101-113.
37. 3H]Nisoxetine: a new radioligand for norepinephrine uptake sites in brain. Eur. J. Pharmacol. 191, 239-243.
38. Thomas, D.N., Holman, R.B., 1991. A microdialysis study of the regulation of endogenous noradrenaline release in the rat hippocampus. J. Neurochem. 56, 1741-1746.
39. Thomas, D.N., Nutt, D., Holman, R.B., 1994. Regionally specific changes in extracellular noradrenaline following chronic idazoxan as revealed by in vivo microdialysis. Eur. J. Pharmacol. 261, 53-57.
40. van Kammen, D.P., Antelman, S., 1984. Impaired noradrenergic transmission in schizophrenia? Life Sci. 34, 1403-1413.
41. van Veldhuizen, M.J.A., Feenstra, M.G.P., Heinsbroek, R.P.W., Boer, G.J., 1993. In vivo microdialysis of noradrenaline overflow: effects of α-adrenoceptor agonists and antagonists measured by cumulative concentration-response curves. Br. J. Pharmacol. 109, 655-660.
42. van Veldhuizen, M.J.A., Feenstra, M.G.P., Boer, G.J., 1994. Regional differences in the in vivo regulation of the extracellular levels of noradrenaline and its metabolites in rat brain. Brain Res. 635, 238-248.
43. Wolfersdorf, M., KoEnig, F., Barg, T., 1997. Monotherapy of delusional depression with zotepine - results of a 28 day monotherapy. Psychopharmacotherapy 4, 149-152.
44. Wong, D.T., Bymaster, F.P., 1996. Effect of nisoxetine on uptake of catecholamines in synaptosomes isolated from discrete regions of rat brain. Biochem. Pharmacol. 25, 1979-1983.